Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou3f4
|
ENSMUSG00000056854.3 | POU domain, class 3, transcription factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_110816292_110817145 | Pou3f4 | 2438 | 0.336423 | 0.85 | 1.1e-17 | Click! |
chrX_110817183_110817473 | Pou3f4 | 3048 | 0.303351 | 0.84 | 2.2e-17 | Click! |
chrX_110818058_110818665 | Pou3f4 | 4081 | 0.274757 | 0.81 | 2.3e-15 | Click! |
chrX_110813381_110813706 | Pou3f4 | 737 | 0.590010 | 0.81 | 4.8e-15 | Click! |
chrX_110814269_110815716 | Pou3f4 | 712 | 0.710672 | 0.80 | 1.3e-14 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_66323360_66324079 | 15.45 |
Map2 |
microtubule-associated protein 2 |
1617 |
0.37 |
chr3_17783692_17784517 | 13.62 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
5817 |
0.2 |
chr13_78189592_78191761 | 11.94 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
233 |
0.9 |
chr16_77418973_77419718 | 9.98 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
2475 |
0.17 |
chrX_166346283_166346827 | 9.68 |
Gpm6b |
glycoprotein m6b |
1713 |
0.43 |
chr3_34653590_34654523 | 9.16 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1980 |
0.2 |
chr2_65620767_65621991 | 9.04 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
568 |
0.82 |
chr13_78193022_78193812 | 8.91 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
2956 |
0.18 |
chr10_29143400_29144848 | 8.76 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr4_22485878_22486449 | 8.72 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
2203 |
0.26 |
chr8_54957960_54958420 | 8.66 |
Gm45263 |
predicted gene 45263 |
1629 |
0.32 |
chr17_93198991_93201483 | 8.58 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr10_29145199_29145467 | 8.34 |
Gm9996 |
predicted gene 9996 |
1139 |
0.36 |
chr4_24429901_24430719 | 7.82 |
Gm27243 |
predicted gene 27243 |
580 |
0.79 |
chr3_80800286_80803016 | 7.77 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
928 |
0.67 |
chr7_16134834_16135297 | 7.67 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
4717 |
0.13 |
chr13_83735228_83735549 | 7.66 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2822 |
0.16 |
chr14_60380755_60381381 | 7.61 |
Amer2 |
APC membrane recruitment 2 |
2782 |
0.3 |
chr13_84905458_84906287 | 7.09 |
Gm4059 |
predicted gene 4059 |
68445 |
0.12 |
chr4_13747506_13748460 | 6.97 |
Runx1t1 |
RUNX1 translocation partner 1 |
3314 |
0.37 |
chr8_109245493_109246323 | 6.93 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
3958 |
0.33 |
chr8_33747278_33748028 | 6.84 |
Smim18 |
small integral membrane protein 18 |
117 |
0.95 |
chr12_27336415_27336825 | 6.71 |
Sox11 |
SRY (sex determining region Y)-box 11 |
5954 |
0.3 |
chr15_92160888_92162023 | 6.59 |
Cntn1 |
contactin 1 |
98 |
0.98 |
chr12_3368833_3369546 | 6.58 |
Gm48511 |
predicted gene, 48511 |
760 |
0.54 |
chr16_28927533_28927764 | 6.57 |
Mb21d2 |
Mab-21 domain containing 2 |
2025 |
0.41 |
chrX_23294952_23295287 | 6.45 |
Klhl13 |
kelch-like 13 |
1039 |
0.66 |
chr17_80946268_80946852 | 6.39 |
Tmem178 |
transmembrane protein 178 |
1928 |
0.35 |
chr18_42897053_42897298 | 6.38 |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
1640 |
0.46 |
chr1_42702274_42702636 | 6.38 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
5597 |
0.14 |
chr8_8655111_8656501 | 6.27 |
Efnb2 |
ephrin B2 |
5433 |
0.1 |
chr2_22624675_22625045 | 6.24 |
Gad2 |
glutamic acid decarboxylase 2 |
1556 |
0.29 |
chr4_9270926_9271667 | 6.10 |
Clvs1 |
clavesin 1 |
159 |
0.96 |
chr16_43507761_43509014 | 5.99 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
124 |
0.97 |
chr5_137553079_137554278 | 5.97 |
Actl6b |
actin-like 6B |
121 |
0.89 |
chr5_37244380_37244680 | 5.95 |
Crmp1 |
collapsin response mediator protein 1 |
1234 |
0.48 |
chr1_84693950_84694415 | 5.91 |
Mir5126 |
microRNA 5126 |
1657 |
0.28 |
chr12_70109243_70109882 | 5.77 |
Nin |
ninein |
2009 |
0.27 |
chr18_81165961_81166641 | 5.69 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69765 |
0.09 |
chrX_110811626_110812334 | 5.62 |
Gm44593 |
predicted gene 44593 |
344 |
0.89 |
chr6_96113911_96115198 | 5.57 |
Tafa1 |
TAFA chemokine like family member 1 |
95 |
0.98 |
chr4_110283517_110283754 | 5.57 |
Elavl4 |
ELAV like RNA binding protein 4 |
2981 |
0.39 |
chr1_143640264_143641520 | 5.51 |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
228 |
0.59 |
chr2_65566312_65566743 | 5.48 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
965 |
0.63 |
chr7_51629095_51630495 | 5.46 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
315 |
0.88 |
chr14_64592977_64593388 | 5.41 |
Mir3078 |
microRNA 3078 |
1997 |
0.25 |
chr1_173389412_173390669 | 5.41 |
Cadm3 |
cell adhesion molecule 3 |
22345 |
0.14 |
chr18_43686213_43686392 | 5.40 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
1323 |
0.49 |
chr1_146494200_146495557 | 5.32 |
Gm29514 |
predicted gene 29514 |
73 |
0.56 |
chr13_75089525_75090889 | 5.28 |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
291 |
0.94 |
chr19_47017205_47017356 | 5.25 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
2127 |
0.2 |
chr13_105248515_105248922 | 5.21 |
Rnf180 |
ring finger protein 180 |
22321 |
0.21 |
chr1_66389272_66389745 | 5.16 |
Map2 |
microtubule-associated protein 2 |
2497 |
0.31 |
chr1_99774053_99774267 | 5.15 |
Cntnap5b |
contactin associated protein-like 5B |
1395 |
0.49 |
chr5_140647120_140647420 | 5.14 |
Ttyh3 |
tweety family member 3 |
1727 |
0.28 |
chr1_42700819_42701404 | 5.14 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
5343 |
0.14 |
chr7_140821200_140821421 | 5.08 |
Zfp941 |
zinc finger protein 941 |
822 |
0.35 |
chr9_91363064_91363717 | 5.06 |
Zic1 |
zinc finger protein of the cerebellum 1 |
336 |
0.72 |
chr4_78209143_78209724 | 5.03 |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
2306 |
0.29 |
chr1_143643096_143643376 | 5.01 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
711 |
0.65 |
chr7_99383478_99385192 | 4.98 |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
1563 |
0.33 |
chr2_116055788_116056761 | 4.97 |
Meis2 |
Meis homeobox 2 |
2568 |
0.25 |
chr12_41483283_41485192 | 4.93 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr5_70842167_70842810 | 4.89 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
129 |
0.98 |
chr1_184997307_184998530 | 4.89 |
Mark1 |
MAP/microtubule affinity regulating kinase 1 |
1557 |
0.41 |
chr19_6499251_6500132 | 4.86 |
Nrxn2 |
neurexin II |
1856 |
0.23 |
chrX_73879571_73879729 | 4.80 |
L1cam |
L1 cell adhesion molecule |
1145 |
0.33 |
chr16_77421091_77421970 | 4.79 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
290 |
0.84 |
chr14_80845815_80846273 | 4.76 |
Gm19120 |
predicted gene, 19120 |
11712 |
0.28 |
chr9_112231189_112232055 | 4.75 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
280 |
0.9 |
chr7_4120918_4121688 | 4.73 |
9430041J12Rik |
RIKEN cDNA 9430041J12 gene |
575 |
0.45 |
chr2_6883618_6884699 | 4.73 |
Gm13389 |
predicted gene 13389 |
112 |
0.85 |
chr8_12324957_12325822 | 4.71 |
Gm33175 |
predicted gene, 33175 |
5909 |
0.18 |
chr12_49387532_49388566 | 4.71 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1603 |
0.26 |
chr3_119154592_119155474 | 4.70 |
Gm43410 |
predicted gene 43410 |
286789 |
0.01 |
chr14_60086016_60087318 | 4.70 |
Atp8a2 |
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
167 |
0.75 |
chr4_22483966_22484156 | 4.67 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
4305 |
0.19 |
chr18_43389837_43390467 | 4.66 |
Dpysl3 |
dihydropyrimidinase-like 3 |
3225 |
0.29 |
chr18_72347121_72347425 | 4.64 |
Dcc |
deleted in colorectal carcinoma |
3744 |
0.36 |
chr11_93101977_93102747 | 4.63 |
Car10 |
carbonic anhydrase 10 |
3072 |
0.4 |
chr16_77236731_77239778 | 4.62 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
1935 |
0.4 |
chr2_73773212_73773983 | 4.53 |
Chn1 |
chimerin 1 |
1446 |
0.44 |
chr7_25004827_25006284 | 4.50 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
340 |
0.79 |
chr7_139833633_139836105 | 4.50 |
Adgra1 |
adhesion G protein-coupled receptor A1 |
93 |
0.96 |
chr13_34132999_34133150 | 4.48 |
Gm36500 |
predicted gene, 36500 |
786 |
0.46 |
chr1_66322405_66322814 | 4.44 |
Map2 |
microtubule-associated protein 2 |
507 |
0.79 |
chr3_34658275_34659470 | 4.44 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
2836 |
0.15 |
chr9_91369028_91370469 | 4.42 |
Zic4 |
zinc finger protein of the cerebellum 4 |
250 |
0.86 |
chr12_27337801_27337952 | 4.41 |
Sox11 |
SRY (sex determining region Y)-box 11 |
4698 |
0.32 |
chr2_114340768_114341209 | 4.41 |
Gm29234 |
predicted gene 29234 |
67553 |
0.12 |
chr12_71049290_71050137 | 4.40 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
1372 |
0.4 |
chr13_8205494_8206737 | 4.38 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
3193 |
0.23 |
chr7_137303017_137303262 | 4.38 |
Ebf3 |
early B cell factor 3 |
10777 |
0.19 |
chr11_55607331_55608633 | 4.37 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr1_177446374_177448525 | 4.37 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr15_23035608_23036941 | 4.33 |
Cdh18 |
cadherin 18 |
181 |
0.97 |
chr3_45384939_45386122 | 4.33 |
Pcdh10 |
protocadherin 10 |
2897 |
0.22 |
chr13_28420292_28420642 | 4.32 |
Gm40841 |
predicted gene, 40841 |
401 |
0.89 |
chr1_42698766_42699058 | 4.31 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
3144 |
0.17 |
chr8_90957042_90957647 | 4.28 |
Chd9 |
chromodomain helicase DNA binding protein 9 |
1909 |
0.31 |
chr3_115774354_115774995 | 4.26 |
Gm9889 |
predicted gene 9889 |
59524 |
0.1 |
chr15_80287617_80288262 | 4.25 |
Cacna1i |
calcium channel, voltage-dependent, alpha 1I subunit |
405 |
0.78 |
chr8_64690831_64691226 | 4.24 |
Cpe |
carboxypeptidase E |
2026 |
0.3 |
chr8_78233052_78233522 | 4.21 |
Ttc29 |
tetratricopeptide repeat domain 29 |
14493 |
0.23 |
chrX_105390628_105392456 | 4.19 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr9_45432313_45432910 | 4.18 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
881 |
0.47 |
chrX_166346941_166347276 | 4.17 |
Gpm6b |
glycoprotein m6b |
2266 |
0.36 |
chrX_66650823_66651841 | 4.17 |
Slitrk2 |
SLIT and NTRK-like family, member 2 |
1675 |
0.36 |
chr9_47533054_47533827 | 4.15 |
Cadm1 |
cell adhesion molecule 1 |
3067 |
0.25 |
chr15_92600107_92600467 | 4.15 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
3161 |
0.38 |
chr16_77594640_77595970 | 4.14 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
403 |
0.71 |
chr3_34654574_34655689 | 4.13 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
905 |
0.42 |
chr13_83732205_83734272 | 4.12 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr12_29529268_29529419 | 4.11 |
Myt1l |
myelin transcription factor 1-like |
942 |
0.56 |
chr2_57613916_57615034 | 4.10 |
Gm13532 |
predicted gene 13532 |
14753 |
0.2 |
chr8_34811262_34812206 | 4.10 |
Dusp4 |
dual specificity phosphatase 4 |
4437 |
0.25 |
chr6_61329658_61330098 | 4.10 |
Ccser1 |
coiled-coil serine rich 1 |
10228 |
0.27 |
chr3_76075315_76075943 | 4.07 |
Fstl5 |
follistatin-like 5 |
46 |
0.98 |
chr4_83742843_83743371 | 4.06 |
Gm26968 |
predicted gene, 26968 |
570 |
0.79 |
chr15_92598307_92599654 | 4.05 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
1854 |
0.49 |
chr1_78193153_78194695 | 4.04 |
Pax3 |
paired box 3 |
2914 |
0.3 |
chr17_91085493_91086001 | 4.03 |
Gm47307 |
predicted gene, 47307 |
2659 |
0.21 |
chr4_109342938_109343450 | 4.02 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
59 |
0.97 |
chr1_81077232_81078427 | 4.00 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr12_49393641_49394061 | 4.00 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
3192 |
0.17 |
chr13_29014902_29016014 | 4.00 |
A330102I10Rik |
RIKEN cDNA A330102I10 gene |
835 |
0.7 |
chr13_83740463_83741042 | 4.00 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1889 |
0.2 |
chrX_103185161_103185695 | 3.98 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
1212 |
0.36 |
chr8_109248831_109249717 | 3.98 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr18_61691759_61692669 | 3.98 |
Gm38165 |
predicted gene, 38165 |
170 |
0.91 |
chr10_87485570_87486803 | 3.98 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
7474 |
0.2 |
chrX_147552308_147552607 | 3.95 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
1593 |
0.47 |
chr15_18819772_18819999 | 3.89 |
Cdh10 |
cadherin 10 |
444 |
0.76 |
chr3_17792584_17792950 | 3.88 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1153 |
0.46 |
chr15_44746196_44747245 | 3.86 |
Sybu |
syntabulin (syntaxin-interacting) |
1068 |
0.56 |
chr2_140666876_140668088 | 3.84 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
3918 |
0.37 |
chrX_69362591_69363214 | 3.83 |
Gm14705 |
predicted gene 14705 |
1633 |
0.4 |
chr1_66322822_66322976 | 3.82 |
Map2 |
microtubule-associated protein 2 |
797 |
0.63 |
chr1_5916517_5917959 | 3.81 |
Npbwr1 |
neuropeptides B/W receptor 1 |
160 |
0.97 |
chr1_115684558_115685809 | 3.80 |
Cntnap5a |
contactin associated protein-like 5A |
427 |
0.58 |
chrX_41403004_41403915 | 3.76 |
Gria3 |
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
719 |
0.76 |
chr9_72533965_72534704 | 3.76 |
Rfx7 |
regulatory factor X, 7 |
1599 |
0.21 |
chr3_84215699_84216651 | 3.74 |
Trim2 |
tripartite motif-containing 2 |
3337 |
0.29 |
chr7_36700944_36701609 | 3.68 |
Tshz3 |
teashirt zinc finger family member 3 |
3059 |
0.18 |
chr12_29536509_29537451 | 3.68 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.36 |
chr4_28143186_28143619 | 3.67 |
Gm11911 |
predicted gene 11911 |
76225 |
0.11 |
chrX_152643367_152644550 | 3.67 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr4_43670757_43671354 | 3.66 |
Tmem8b |
transmembrane protein 8B |
1140 |
0.22 |
chr7_36703759_36704512 | 3.65 |
Tshz3 |
teashirt zinc finger family member 3 |
5918 |
0.14 |
chr12_89816860_89817842 | 3.62 |
Nrxn3 |
neurexin III |
4868 |
0.35 |
chr15_25019572_25019925 | 3.62 |
Gm2824 |
predicted gene 2824 |
1354 |
0.54 |
chr9_60686843_60686994 | 3.62 |
Lrrc49 |
leucine rich repeat containing 49 |
616 |
0.74 |
chr13_83726534_83727321 | 3.60 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1179 |
0.35 |
chr17_72602085_72602577 | 3.60 |
Alk |
anaplastic lymphoma kinase |
1496 |
0.51 |
chr6_112943851_112944495 | 3.59 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
2581 |
0.19 |
chr14_119857212_119858081 | 3.59 |
4930404K13Rik |
RIKEN cDNA 4930404K13 gene |
58668 |
0.13 |
chr7_141945515_141946556 | 3.51 |
Gm20501 |
predicted gene 20501 |
78 |
0.96 |
chr2_143547529_143548278 | 3.51 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
66 |
0.97 |
chr10_64089736_64090806 | 3.51 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
3 |
0.99 |
chr11_117656414_117656565 | 3.50 |
Tnrc6c |
trinucleotide repeat containing 6C |
1676 |
0.36 |
chr10_6790825_6791573 | 3.50 |
Oprm1 |
opioid receptor, mu 1 |
2100 |
0.4 |
chr6_55678280_55679200 | 3.50 |
Neurod6 |
neurogenic differentiation 6 |
2523 |
0.32 |
chr3_67892808_67893503 | 3.50 |
Iqschfp |
Iqcj and Schip1 fusion protein |
923 |
0.42 |
chr3_13470890_13471041 | 3.50 |
Ralyl |
RALY RNA binding protein-like |
690 |
0.51 |
chr10_49785211_49786117 | 3.48 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2255 |
0.25 |
chr1_42709764_42710511 | 3.48 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
2085 |
0.24 |
chr1_89549979_89550754 | 3.47 |
Gm25180 |
predicted gene, 25180 |
12994 |
0.18 |
chr4_33927772_33928010 | 3.47 |
Cnr1 |
cannabinoid receptor 1 (brain) |
1689 |
0.47 |
chr17_51584469_51584834 | 3.45 |
Gm31143 |
predicted gene, 31143 |
49793 |
0.14 |
chr15_44704719_44704870 | 3.45 |
Sybu |
syntabulin (syntaxin-interacting) |
42994 |
0.15 |
chr1_66176824_66177184 | 3.45 |
Map2 |
microtubule-associated protein 2 |
1454 |
0.52 |
chr15_40533600_40534035 | 3.43 |
Gm7382 |
predicted gene 7382 |
3504 |
0.28 |
chr8_55939901_55941088 | 3.42 |
Glra3 |
glycine receptor, alpha 3 subunit |
15 |
0.98 |
chr18_88040282_88040879 | 3.42 |
Gm50391 |
predicted gene, 50391 |
55970 |
0.16 |
chr5_147189740_147190929 | 3.42 |
Gsx1 |
GS homeobox 1 |
1638 |
0.31 |
chr14_124675118_124677112 | 3.42 |
Fgf14 |
fibroblast growth factor 14 |
1012 |
0.63 |
chr5_111425949_111427685 | 3.42 |
Gm43119 |
predicted gene 43119 |
3228 |
0.22 |
chr5_48598987_48600332 | 3.41 |
Kcnip4 |
Kv channel interacting protein 4 |
23 |
0.97 |
chr5_106003554_106004357 | 3.41 |
Gm19566 |
predicted gene, 19566 |
22773 |
0.18 |
chr14_122480308_122481080 | 3.41 |
Zic2 |
zinc finger protein of the cerebellum 2 |
2594 |
0.16 |
chr3_17790851_17791260 | 3.41 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1098 |
0.49 |
chr6_64799057_64799968 | 3.40 |
Atoh1 |
atonal bHLH transcription factor 1 |
70387 |
0.11 |
chr1_72827809_72827961 | 3.40 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
2563 |
0.32 |
chr5_35454181_35454829 | 3.39 |
Gm43377 |
predicted gene 43377 |
58407 |
0.08 |
chr3_118432535_118432944 | 3.38 |
Gm26871 |
predicted gene, 26871 |
1058 |
0.3 |
chr8_112570000_112570856 | 3.38 |
Cntnap4 |
contactin associated protein-like 4 |
373 |
0.76 |
chr13_101234142_101234529 | 3.38 |
5930438M14Rik |
RIKEN cDNA 5930438M14 gene |
2208 |
0.35 |
chr16_77235848_77236417 | 3.36 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
185 |
0.96 |
chr2_116042897_116043685 | 3.36 |
Meis2 |
Meis homeobox 2 |
1245 |
0.46 |
chr1_131137062_131137477 | 3.35 |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
976 |
0.46 |
chrX_158924759_158924985 | 3.33 |
Gm5764 |
predicted gene 5764 |
91437 |
0.09 |
chr2_170733371_170733888 | 3.32 |
Dok5 |
docking protein 5 |
1822 |
0.45 |
chr2_129698961_129700174 | 3.29 |
Pdyn |
prodynorphin |
266 |
0.93 |
chr13_84404605_84405288 | 3.28 |
Gm26927 |
predicted gene, 26927 |
64833 |
0.12 |
chr8_96455054_96456367 | 3.26 |
Gm32122 |
predicted gene, 32122 |
51848 |
0.14 |
chr6_45062685_45062917 | 3.26 |
Cntnap2 |
contactin associated protein-like 2 |
2740 |
0.24 |
chr1_168676421_168677250 | 3.25 |
1700063I16Rik |
RIKEN cDNA 1700063I16 gene |
953 |
0.73 |
chr17_3610552_3611747 | 3.25 |
1700102H20Rik |
RIKEN cDNA 1700102H20 gene |
53280 |
0.12 |
chr3_26331036_26332158 | 3.24 |
Nlgn1 |
neuroligin 1 |
273 |
0.58 |
chr9_71891771_71892231 | 3.23 |
Tcf12 |
transcription factor 12 |
3984 |
0.14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.3 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
3.0 | 9.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.2 | 8.8 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.2 | 8.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.2 | 6.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.1 | 6.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.0 | 6.1 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.0 | 17.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.7 | 5.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.7 | 3.3 | GO:0060594 | mammary gland specification(GO:0060594) |
1.6 | 12.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.5 | 10.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.5 | 4.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.3 | 6.4 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.2 | 3.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.2 | 7.2 | GO:0060174 | limb bud formation(GO:0060174) |
1.2 | 3.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.1 | 4.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.1 | 3.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.1 | 3.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
1.1 | 2.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.1 | 4.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.0 | 3.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.9 | 6.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.9 | 8.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.9 | 4.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.8 | 3.4 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.8 | 1.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.8 | 2.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.8 | 2.4 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.8 | 2.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.8 | 3.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.8 | 1.6 | GO:1904398 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
0.8 | 9.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.8 | 3.8 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.8 | 4.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.7 | 3.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.7 | 2.9 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.7 | 2.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.7 | 2.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.7 | 4.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.7 | 6.8 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.7 | 6.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.7 | 1.3 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.7 | 2.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 2.0 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.6 | 3.2 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.6 | 2.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.6 | 1.3 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.6 | 1.9 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.6 | 3.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.6 | 2.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 1.8 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.6 | 1.8 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 3.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.6 | 5.5 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.6 | 4.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.6 | 1.8 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.6 | 4.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.6 | 2.3 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.6 | 1.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 2.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.6 | 1.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.6 | 2.2 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.5 | 2.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.5 | 0.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.5 | 1.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.5 | 7.2 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.5 | 1.5 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 1.5 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 1.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 4.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 4.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.5 | 1.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 1.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 2.3 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.5 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 4.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 1.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.5 | 5.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.5 | 5.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.4 | 1.3 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.4 | 1.8 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.4 | 0.9 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.4 | 1.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.4 | 0.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.4 | 2.6 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.4 | 3.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.4 | 2.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 6.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 0.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.4 | 1.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 1.6 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.4 | 2.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.4 | 1.5 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 1.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.4 | 3.4 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.4 | 0.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 1.5 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.4 | 2.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 6.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 2.9 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.4 | 19.1 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.4 | 1.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 17.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 0.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 2.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 2.1 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.3 | 1.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 27.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.3 | 1.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 0.3 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.3 | 0.6 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 1.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 2.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 1.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 0.6 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.3 | 3.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 0.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 1.4 | GO:0071625 | vocalization behavior(GO:0071625) |
0.3 | 1.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.3 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.3 | 1.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 0.5 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.3 | 0.3 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 0.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 1.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.3 | 1.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.3 | 0.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.3 | 0.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 2.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.3 | 1.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 0.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 0.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 2.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 1.8 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.3 | 2.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 0.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 0.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.3 | 0.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.3 | 1.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.3 | 0.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 0.7 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.2 | 3.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 4.4 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.2 | 0.5 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 1.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 0.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 0.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 0.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 1.2 | GO:0051938 | L-glutamate import(GO:0051938) |
0.2 | 1.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 1.2 | GO:0001964 | startle response(GO:0001964) |
0.2 | 1.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.5 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 0.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.2 | 2.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.9 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.2 | 0.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 0.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 2.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.9 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.7 | GO:0072017 | distal tubule development(GO:0072017) |
0.2 | 1.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 2.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.9 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 0.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 7.8 | GO:0008542 | visual learning(GO:0008542) |
0.2 | 0.4 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.2 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.6 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.2 | 0.4 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 1.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 0.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.4 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.2 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 3.1 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.4 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.2 | 1.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.4 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.4 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.2 | 0.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.6 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 0.4 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 0.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 0.2 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.2 | 0.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 1.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 1.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 0.2 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.2 | 0.6 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.1 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.7 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.2 | 0.5 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 0.2 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.2 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 3.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 2.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 0.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 1.2 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.2 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.5 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 2.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.5 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 1.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 0.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 0.3 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.2 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 11.2 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.2 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 4.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 1.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.1 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 5.6 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 1.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.6 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.4 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 5.6 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 2.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.5 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 2.0 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.6 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.4 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 3.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.7 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.5 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 1.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 5.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.3 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.1 | 0.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 1.4 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.2 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.1 | 0.9 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 1.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.9 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.1 | GO:0051794 | regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) |
0.1 | 0.6 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.3 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.5 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.2 | GO:0060872 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.1 | 0.1 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.1 | 2.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 4.2 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.1 | 0.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.3 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.4 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 0.2 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 1.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.5 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.3 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.2 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 1.4 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.4 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.2 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.1 | 0.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 1.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 0.2 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 2.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.9 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.9 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.4 | GO:0001840 | neural plate development(GO:0001840) |
0.1 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 1.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.1 | GO:0046958 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
0.1 | 0.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.1 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.1 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.1 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.6 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.1 | 0.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.1 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.2 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.2 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.1 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 0.9 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.2 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.1 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.2 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.1 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.7 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.2 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 0.4 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 3.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.9 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.4 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.4 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:0061183 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.0 | 0.1 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.0 | 0.1 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.0 | 0.3 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.2 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.3 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.0 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.3 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.2 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.0 | 0.6 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.2 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.0 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.0 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.0 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.0 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.0 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.0 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.0 | 0.2 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.0 | 0.1 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.0 | 0.4 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.0 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.0 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.0 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.2 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.1 | GO:2000562 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.0 | 0.8 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.5 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.0 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0019076 | viral release from host cell(GO:0019076) |
0.0 | 0.1 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.0 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.0 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.3 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 2.0 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.0 | 0.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.0 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.0 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.0 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.1 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.8 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.0 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.5 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.0 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.0 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.0 | 0.0 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.0 | 0.3 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.3 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.0 | 0.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.1 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.1 | GO:0034728 | nucleosome organization(GO:0034728) |
0.0 | 0.2 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.1 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.0 | 0.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.0 | GO:0044849 | estrous cycle(GO:0044849) |
0.0 | 0.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.0 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) |
0.0 | 0.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.5 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.2 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.0 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.0 | GO:0070836 | caveola assembly(GO:0070836) |
0.0 | 0.1 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.0 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.0 | 0.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.4 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.0 | 0.0 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.0 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.0 | 0.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.0 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 8.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 3.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.0 | 7.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.0 | 7.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.9 | 0.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.9 | 2.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 5.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.9 | 0.9 | GO:0035838 | growing cell tip(GO:0035838) |
0.9 | 4.5 | GO:0097433 | dense body(GO:0097433) |
0.8 | 3.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.8 | 5.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 21.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.7 | 38.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 5.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 7.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 4.9 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 0.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.6 | 8.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 9.9 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 7.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 4.2 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 1.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.5 | 5.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.5 | 1.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.5 | 2.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 1.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 0.5 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.4 | 2.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 2.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.4 | 1.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 10.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 4.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 1.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 0.7 | GO:0044393 | microspike(GO:0044393) |
0.3 | 1.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 2.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 1.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 10.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 1.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 8.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.3 | 1.2 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 6.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 4.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 4.1 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 3.1 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 6.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 0.8 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 7.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 1.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 5.4 | GO:0044298 | cell body membrane(GO:0044298) |
0.2 | 0.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 14.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.6 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 7.4 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 24.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 1.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 10.4 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 18.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 1.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 1.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.3 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.9 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 2.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 5.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 1.7 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 1.7 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 1.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 1.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.0 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.4 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 1.9 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.0 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 0.0 | GO:0071546 | pi-body(GO:0071546) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
4.0 | 20.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.6 | 7.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.3 | 9.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.3 | 13.7 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.4 | 12.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.1 | 3.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.0 | 4.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.9 | 2.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.9 | 2.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.9 | 2.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.8 | 1.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.7 | 8.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 5.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 6.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 3.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.6 | 2.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 1.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.6 | 1.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.6 | 1.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.6 | 2.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.6 | 3.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.6 | 3.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 10.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.6 | 2.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.6 | 13.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 6.7 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.6 | 2.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 2.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 7.1 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 1.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 1.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 8.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.5 | 3.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.5 | 1.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 3.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.5 | 2.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 1.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 1.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.5 | 1.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.5 | 1.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.4 | 1.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 6.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.4 | 1.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 7.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 2.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 1.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 0.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 1.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 7.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 1.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 3.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 0.6 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 0.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 1.9 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 5.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 2.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 6.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.3 | 1.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 2.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 1.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.7 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 2.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.2 | 2.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.6 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 0.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 1.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 4.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 6.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 2.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 4.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 1.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 1.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 1.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 2.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.9 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 3.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 1.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 1.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 4.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 3.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.2 | 1.1 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 2.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 4.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 2.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 1.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 1.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 1.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.4 | GO:0018590 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 2.4 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 0.1 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 2.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.4 | GO:0001226 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 1.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 1.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.5 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 1.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.3 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.3 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 1.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 5.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.1 | 0.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 1.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 2.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 1.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 1.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 1.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.2 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.1 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 7.4 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.1 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 1.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.1 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 4.0 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 3.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 1.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 1.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 1.1 | GO:0009975 | cyclase activity(GO:0009975) |
0.1 | 2.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 1.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 1.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 3.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 1.9 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.2 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 4.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.6 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.2 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 1.1 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.0 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 3.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.0 | GO:0001030 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 1.9 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.3 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.0 | 0.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | ST ADRENERGIC | Adrenergic Pathway |
0.4 | 18.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 15.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 9.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 3.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 5.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 12.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 1.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 5.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 4.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 1.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 2.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 26.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 18.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.7 | 6.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.7 | 13.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 9.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.6 | 4.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 5.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.5 | 0.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 2.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 6.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 8.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 3.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 8.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 3.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 0.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.3 | 13.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 2.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 4.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 3.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 7.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 2.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 0.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 2.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 1.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 7.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 1.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 3.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 3.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 2.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 4.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 2.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 3.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 3.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 3.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 2.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.7 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 3.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 1.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.0 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.4 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |